in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Lonza Struggles in the Face of Lower Demand (update)
7:19 AM MST | January 28, 2010 | Alex Scott
Fine chemicals group Lonza says its Ebitda for full year 2009 fell 4.8% to SF 658 million ($626 million) on corresponding sales down 8.4% to SF2.7 billion. The company says it experienced lower demand across all of its businesses. Despite “volatility” in the market Lonza secured a stable Ebitda margin of 24.5%. Although 2009 was a tough year, “all businesses are profitable and remain strategically sound,” the company says. Lonza's CEO Stefan Borgas in the past hour told journalists and anlaysts that although there remains volatility in the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee